T-B cell interactions have a central role in the development of antibody responses. Upon activation, T helper (Th) cells express the ligand for CD40, gp39, which is essential for Th cell-dependent B cell activation. The cytokines produced by activated Th cells have a regulatory role in B cell differentiation. In this study, we investigated, using immunohistochemical techniques, the in vivo time course and localization of gp39 expression and cytokine production in relation to the specific antibody production. Both the immunization with keyhole limpet hemocyanin (KLH), a thymus-dependent (TD) antigen, and trinitrophenyl (TNP)-FicoU, a thymus-independent type 2 (TI-2) antigen, induced Th cells to express gp39. The expression of gp39 was restricted to Th cells in the outer periarteriolar lymphocyte sheaths (outer-PALS) and around the terminal arterioles (TA). Incidentally, gp39 + Th cells were found in the corona of follicles, whereas gp39 + cells were never found in the germinal centers or marginal zones of the spleen. Maximum frequencies of gp39 + cells were observed 3 and 4 d after primary and secondary immunization with KLH. After injection of TNP-Ficoll, a marked increase in gp39 + cells was observed, confirming previous observations that activated T cells are involved in TI-2 antibody responses. Analysis of the in vivo cytokine production revealed that interleukin 2 (IL-2)-, IL-4-and interferon 3/ (IFN-q0-producing cells (IFN-q/-PC) developed according to similar kinetics as observed for gp39 + cells. IL-2-PC and IL-4-PC were present in higher frequencies as were IFN-3/-PC in the immune response against TNP-KLH. Double staining experiments revealed gp39 + Th cells producing IL-2, IL-4, or IFN-% suggesting that these cells were involved in both the initial activation as well as the differentiation process of B cells into antibody-forming cells. Dual immunohistochemical analysis revealed gp39 + T cells and cytokine-PC in close proximity to antigen-specific, antibody-forming B cells. In conclusion, this study shows that in vivo gp39 is expressed on activated Th cells after immunization with TD and TI-2 antigens. Furthermore, the time course and compartmentalization of gp39 + expression, cytokine production and antibody formation after immunization suggest that cognate T-B cell interactions and T cell-regnlated B cell differentiation occur in the outer-PALS and around the TA of the spleen.
antigen-specific Th cells with B cells. None of the molecularly cloned cytokines, alone or in combination, can replace the contact-dependent requirement for B cell activation (1) (2) (3) . The molecule that mediates the contact-dependent signal was identified as a membrane protein that is expressed on the surface of activated Th cells (4, 5) . This membrane protein, gp39, was identified as the ligand for the B cell membrane protein CD40 . In vitro studies using gp39-bearing plasma membranes from activated Th cells showed that these plasma membranes induce the activation of resting B cells (6, 7) . A soluble, CD40-Ig fusion protein and a gp39-specific mAb were able to block the activation of B cells by these plasma membranes (5) . Recently, several groups (8) (9) (10) (11) showed that mutations in gp39 are responsible for the defective antibody production in patients with X-linked hyper-IgM syndrome, indicating that this molecule expressed by activated Th cells is essential for humoral immunity. Isolation of cDNA clones encoding mufine (4) and human gp39 (12) showed that this molecule encodes a type II membrane protein. Comparison of the predicted gp39 amino acid sequence with those of other published protein sequences shows that gp39 is homologous to TNF-a and -~ (12, 13) .
After the initial B cell activation by gp39, Th cell-derived cytokines regulate the differentiation of B cells into antibodyforming B cells (6, 7) . The pattern of cytokine secretion by Th cells has been suggested to be decisive in the selection of isotype produced by ankibody-forming B cells (14) (15) (16) . It has been shown in vitro that Thl cells (17) , which secrete IL-2 and IFN-'y, promote IgM and IgG2a secretion by B cells, whereas Th2 cells (IL-4 and IL-5) stimulate B cells to produce antibodies of IgG1 and IgE isotypes (14) (15) (16) . The putative central role of gp39 and cytokines in the initiation and development of humoral immunity is mainly based on in vitro studies. To date, no data has been presented about the simultaneous expression of gp39 and cytokines during in vivo antibody responses. Furthermore, the role of gp39 in in vivo antibody responses has not been addressed. A companion paper by Foy et al. (18) demonstrates that gp39 is essential for the induction of in vivo antibody responses against various TD antigens. This study describes the in vivo development and localization of gp39 + cells and cytokine-producing cells in relation to antigen-specific antibody formation.
Materials and Methods
Animals. BCBA.Fx (C57BL • CBA) mice were bred at the TNO breeding facilities (Rijswijk, The Netherlands). Animals were used at 16-24 wk of age and were kept under a standard protocol with flee access to pelleted food and acidified water (pH 3). Experiments were performed under the auspices of the Dutch Veterinary Inspection, as described in the law on animal experiments.
Chemicals. Alkaline (AP; P-6774, type VII-T, 1,020 U/mg protein), 3-amino-9-ethylcarbazole (AEC; A5754), CFA, 3,3-diaminobenzidine-tetrahydrochloride, Fast blue BB Base, Fast red, horseradish peroxidase (HKP), IFA levamisole, and naphthol AS-MX phosphate (3-hydroxy-2-naphtoic acid 2,4-dimethyl-anilide were obtained from Sigma Chemical Co. (St. Louis, MO) N-hydroxysuccinimidyl-(biotinamido)-hexanoate and maleimidohexanoyl-n-hydroxysuccinimide ester were obtained from Pierce (Rockford, IL). B-Gal (Escherichia coli derived /3-n-Gal galactohydrolase, 540,000), and X-Gal (5-bromo-4-chloro-3-indolyl-B-D-galactopyranoside) were obtained from Boehringer Mannheim (Mannheim, FRG).
Reagents. TNP-Ficoll and TNP-KLH were prepared as previously described (19, 20) . The rat mAb Lyt2 + (CD8) (clone 53.6.7.2) (21) and L3T4 (CD4) (clone GK-1.5) (22) were used as cell markers. The control hamster antibodies and ascites from the cell lines MK1 (5), a mAb directed to gp39 and KG7, a mAb specific for rat/hamster Igg (KG-7; 23) chain were purified by means of a protein A column. Anti-human IgG1 (3.1.1; 24) and human IgG1 were obtained from Nordic Immunological Labs (Tilburg, The Netherlands). The routine mAb DB-1 directed to IFN-% was a kind gift of Dr. P. H. van der Meide (25) from our Institute. The cells of the rat mAb 11Bll, directed to IL-4, and II.-4 were a kind gift of Dr. W. E. Paul (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD [26] ). The IL2-specific mAb, $4B6, was a kind gift of Dr. T. Mosmann (17) . Control rat mAbs (2A4, 1Gll) were a kind gift of Dr. A. Zantema (Sylvius Laboratory, Leiden, The Netherlands [27] ). Recombinant mouse IL-2 was obtained from Genzyme Corp. (Cambridge, MA). The X6310 cell lines producing II.,4 or IL-2 were a kind gift of Dr. F. Melchers (Basel Institute of Immunology, Basel, Switzerland [28] ). Antibodies were purified from culture supernatants using an affinity chromatography goat anti-rat Ig column. Cytokine-specific, gp39-specific, and control antibodies were conjugated to AP and HRP, as previously described (29) . Conjugation to 3-Gal was performed according to the procedure described by Deelder and De Water (30) with minor modifications (31) . TNP-AP and KLH-HRP were prepared according to the previously described methods (19, 20) . Imraunohistochemistry. Splenic cryostat sections (-20~ 8 #m), one of every mouse, were picked up on the same glass slide and kept overnight under high humidity at room temperature. Slides were air-dried and stored in airtight boxes until use. Slides were fixed for 10 min in acetone containing 0.02% H202. Slides were incubated horizontally overnight at 4~ with primary cytokinespecific, antibody conjugates diluted in PBS containing 0.1% BSA and titrated to obtain optimal results. Immunohistochemical demonstration of gp39 was performed in two ways: first, with a gp39-specific hamster mAb, MR-l, followed by a hamster Ig-specific mAb, KG-7, conjugated to peroxidase; second, with a fusion protein of the gp39 receptor, CD40-IgG1 (5), followed by a human IgGl-specific mAb conjugated to peroxidase. For double staining of gp39 and CD4 or CDS, spleen sections were incubated simultaneously with MK-1-AP and L3T4-HKP or Lyt2 +-HKP. Detection of KLH-specific antibody-forming cells (KLH-AFC) and TNP-AFC were detected according to previously described methods (19, 20) . Slides were washed with PBS (three times for 5 min) and immunohistochemical revelation was performed as described previously; AP (29) , HRP (29) , and fl-Gal (30) . For double staining, the immunohistochemical revelation of AP was performed before HKP, and the B'gal staining before AP or HKP, because both the peroxidase substrate and the AP substrate were found to inhibit the/3-gal activity. To ensure that no over-or understaining occurred, slides with adherent substrate solution were monitored by light microscopy during histochemical reactions. Sections were counterstained with hematoxylin and mounted in glycerin gelatin. AFC, gp39 + cells, and cytokine-producing cells (PC) were counted, and image analysis was performed as previously described (32) . A minimum of three sections of each mouse were examined.
Results

Gp39
Expression in Immune Spleen. Spleen sections from mice immunized with KLH were stained for the expression of gp39. Two gp39-specific reagents were used for detection: first, MR1, a gp39-specific mAb, and second, CD40-IgG1, a soluble, recombinant fusion protein of the gp39 receptor and IgG1. In serial spleen sections, CD40-IgG1 and anti-gp39 identified the same number of cells, which were localized in identical anatomical locations (Fig. 1, A and B ; Table 1 ). Moreover, MR1 blocked the staining with CD40-IgG1 in a dose-dependent manner, confirming the fact that MR1 and CD40-IgG1 recognize the same molecule, gp39 (5). Immunohistochemical double staining, using anti-gp39 and anti-CD4 mAb, showed that gp39 expression was restricted to the CD4 lineage cells (Fig. 1 C) .
Localization and Kinetics of gp39 + Cells in Lymphoid Tissue.
Gp39 + Th cells were found predominantly in the outerperiarteriolar lymphocyte sheaths (PALS) and around the terminal arterioles (TA) of the spleen (Table 1 , Figs. 1/1 and 2B). Double staining for CD4 + and gp39 clearly revealed that CD4 + cells in primary follicles were not gp39 positive ( Fig. 1 C) . After secondary immunization, only a few gp39 + cells were observed in the follicular corona, but not in the germinal centers (GC) of secondary follicles ( Fig. 1  A) . Examination of lymph node sections of TNP-KLH immunized mice revealed that gp39 § cells were localized in the deep cortex and along the medullary cords ( Fig. 1 B) . Incidentally, gp39 § cells were observed in the corona, but not in the GC, of follicles in lymph nodes (data not shown). At day 3 and 4 after injection of KLH, we observed the maximum number of gp39 § cells (Fig. 3) . Thereafter, the number decreased and remained stable during the next 3 d. Another group of mice was boosted 16 wk later with KLH. Already during the first 2 d after secondary immunization we observed a striking increase in the number of gp39 + cells, which was markedly higher as compared to the primary response. After 4 d, the gp39 + cells reached maximum numbers, which were about two times higher as we observed during the primary immune response against KLH (Fig. 3) . Immunization with TNP-Ficoll, a thymus-independent type 2 (TI-2) antigen, resulted in an increase in the frequency of gp39 + Th cells, attaining maximum frequencies 5 d after injection (Fig. 4) . As was observed for TD antigens, in the antibody response against TNP-Ficoll, gp39 + cells were localized in the outer-PALS and around the TA of the spleen (Fig. 2 B) . No gp39 expression was observed in the splenic follicles of mice immunized with TNP-Ficoll.
Localization and Kinetics of Cytokine-producing Cells in the
Spleen. Th cell-derived cytokines have a decisive role in isotype selection (14) (15) (16) . As antibody responses against TNP-KLH are dominated by IgG1 antibodies, we investigated whether a Th subset (Thl/Th2) was preferentially activated and where these cytokine-PC were localized in the spleen. Detection of cytokine-PC was performed with cytokinespecific mAb conjugated to different enzymes on splenic cryostat sections of TNP-KLH immunized mice. The IL-4-specific mAb (11Bll) conjugated to B-gal was used for the in situ demonstration of IL-4-PC. After immunohistochemical revelation, IL-4-PC characterized by a turquoise cytoplasm were detected (Fig. 1 D) . No staining was observed in control slides from any specimen treated by omission or substitution of the primary antibody. Preincubation of 11Bll conjugated to fl-gal with recombinant IL-4 inhibited the staining of IL-4-PC, in a dose-dependent manner. Moreover, the specificity of the staining was confirmed on cytospin preparations of cells from an IL-4-producing cell line (X6310-IL-4). IL-2-PC were demonstrated with an IL-2-specific mAb ($4B6) conjugated to HRP and were characterized by a redstained cytoplasm, respectively (data not shown). Control immunoconjugates showed no staining. Furthermore, the specific staining was inhibited by recombinant IL-2 in a dose-dependent manner. In addition, specificity was confirmed on cytospin preparations of cells from an IL-2-producing cell line (X6310-IL-2). The specific demonstration of IFN-7-PC, with an IFN-7-specific mAb (DB-1) conjugated to alkaline phosphatase, was performed as described previously (32, 33) . In all spleen sections examined, cytokine-PC were observed in the outer-PALS and around the TA of the spleen. Cytokine-PC were never observed in the follicles or marginal zone of the spleen. Analysis of the kinetics of cytokine-PC revealed higher frequencies of IL-2-PC and IL-4-PC, relative to IFN-3'-PC, in the antibody response against TNP-KLH, reaching maximum frequencies at 3-4 d after immunization (Fig. 5) .
Cytokine Production by gp39 + Cells. Gp39 + cells are a prerequisite for B cell activation in vitro (5) and TD antibody responses in vivo (18) . Thereafter, cytokine-producing Th cells are thought to be active as regulators of antibody responses. To investigate whether gp39 + cells have the capacity to produce cytokines, as was suggested by in vitro experiments (34), we performed double-staining experiments. MR-1 (gp39) was conjugated to AP, whereas $4B6 (IL-2) and 11Bll (IL-4) were conjugated to HRP and fl-Gal, respectively. Double staining for IFN-7 and gp39 was performed with a direct IFN-7-specific conjugate and MR-1 followed by a secondary HRP-conjugated mAb directed to hamster Ig. Double staining for IL-2 and gp39 revealed red-stained cells producing IL-2, blue-stained gp39 + cells, and violet double-staining cells, representing gp39 * cells producing IL-2 (data not shown). In the case of IL-4 and gp39, the turquoise-stained cells were IL-4-PC and the red-stained cells were gp39 +, whereas double-staining violet cells were gp39 + cells producing IL-4 (Fig. 1 D) . After double staining for IFN-7 and gp39, we observed blue-stained IFN-7-PC, red-stained gp39 + cells, and double-staining violet cells, representing gp39 + cells producing IFN-7 (data not shown). In the spleen, gp39 + cells producing IL-2, IL-4, or IFN-7 were found both during TD and as TI-2 antibody responses.
Kinetics and Localization of Antigen-specific AFC. Using KLH-HRP and TNP-AP conjugates, we were able to study the development of KLH-AFC and TNP-AFC in the spleen after immunization with KLH or TNP-KLH (35) . As demonstrated in Figs. 3 and 4 , in both experiments the kinetics of when antibody-forming B cells, specific for the immunizing antigen, were revealed, the KLH-AFC/TNP-AFC were found in close proximity to the gp39 § Th cells (Fig. 2 A) . Also in the immune response against TNP-FicoU we observed antigen-specific B cells (TNP-AFC) colocalizing with gp39 + cells in the outer-PALS and around the TA (Fig. 2 B) .
KLH-AFC or TNP-AFC developed according to similar patterns attaining maximum frequencies at 4 d after immunization. The frequency of TNP-(hapten)-specific AFC was about 10 times higher than the detected frequency of AFC specific for the carrier (KLH). After boosting with KLH we found
Discussion
The present study demonstrates that during in vivo antibody responses gp39 expression and cytokine production develop simultaneously and are predominantly localized in the outer-PALS and around the TA of the spleen. The gp39 + cells and cytokine-PC are found in close proximity to antigenspecific B ceils. These results suggest that the initial Th cell induced B call activation and the subsequent Th ceil regulated B cell differentiation occur in restricted compartments of the spleen. Furthermore, high frequencies of IL-4-PC, rdative to IFN-y-PC, are found in the immune response against TNP-KLH.
In the primary antibody response against KLH, maximum frequencies of gp39 § Th ceils were observed 3-4 d after intravenous immunization (Fig. 3) . Later, during the course of the immune response, reduced numbers of gp39 + Th ceils were present. ParaUd studies using KLH-primed mice showed that upon secondary immunization with KLH, a significant increase in gp39 + Th ceils was observed within 24 h (Fig.  3) . Maximum frequencies in the secondary response were reached at day 4 and were about twice as high as those observed during primary responses. This observation is in agreement with the results described in the accompanying paper (18) , which shows a twofold increase in helper activity after adoptive transfer of SRBC-immunized spleen cells. Furthermore, the kinetics of appearance of gp39 § Th cells and KLH-AFC were superimposable (Fig. 3) . In vitro studies using Th cell dories have demonstrated that gp39 is rapidly expressed upon triggering with anti-CD3 mAb (5) . Data presented herein document that in vivo administration of antigen induces a rapid expression of gp39 on CD4 § Th cells. The simultaneous development of gp39 + calls and KLH-AFC, together with the demonstration of gp39 § Th calls in close proximity to KLH-AFC, suggest that gp39 expression plays a role in the specific antibody production. This is substantiated by experiments described in the accompanying paper (18) which show that anti-gp39 mAb were able to significantly reduce the antibody responses to KLH in vivo.
It is well known that rigorous T cell depletion completely abrogates the anti-TI-2 antibody response, indicating that T ceils are necessary for a bona fide TI-2 response (36-38). The observed high frequency of gp39 § Th cells after immunization with TNP-Ficoil was surprising, given the fact that the antibody responses to TNP-Ficoil were unaffected in vivo after administration of anti-gp39 mAb (18) . This finding shows that gp39 expression on T cells in the spleen by itself is not enough to activate B ceils or could indicate that gp39 detected in the spleen sections is not the same gp39 that seems to be necessary for TD antibody responses in vivo. The process of T cell activation, revealed in vivo as an increase in the number of gp39 + Th ceils, could be explained as suggested by DeKruyff et al. (39) , who showed in vitro that in TI-2 immune responses, activated B ceils were responsible for the activation of T ceils. Similar results were described by Zisman et al. (40) , who demonstrated that TI-2 antigens, composed of D amino acids which bind to class II molecules of APCs, were able to activate T cells. These activated T ceils can produce cytokines, as was demonstrated in vitro (40) and in vivo (32) , and may regulate the proliferation and differentiation of B ceils activated by TI-2 antigens (41) .
Analysis of the kinetics of cytokine-PC revealed that IL-2-PC and IL-4-PC were predominant in the antibody response against KLH with maximum frequencies at 3-4 d after immunization. The IFN-3,-PC were also found to be active in this immune response, reaching maximum levels at day 3, but the number of IFN-~/-PC was low as compared with the number of IL-2-PC and IL-4-PC. Bradley et al. (42) observed that the kinetics of appearance of effector CD4 + T ceils that produce cytokines upon restimulation with KLH in vitro were similar for each of the cytokines investigated. These results confirm our in vivo findings and suggest that after immunization and subsequent antigen presentation, T cells with potency to produce IL-2, and/or IL-4, IL-5 and/or IFN-~/are activated at about the same time and differentiate into cytokine-PC, following a similar time course. At the peak of the immune response, we observed relatively high frequencies of IL-2-PC and IL-4-PC in the outer-PALS and around the TA. As these cytokine-PC were observed in close conjunction, it is likely that these cells create a microenvironmerit which is rich in IL-2 and IL-4. Such a microenvironment has been suggested to be essential for the development IL-4-PC, as was demonstrated in vitro (43) (44) (45) . These experiments suggested that IL-2 was required for the optimum proliferation of cytokine-producing T cells (43) (44) (45) (46) , whereas IL-4 would propagate the preferential development of IL-4-PC (43, 44) . After double staining, we were able to detect TNP-AFC in dose proximity to cytokine-PC (data not shown), suggesting that these cytokines have a role in B cell differentiation. Nossal and Riedel (47) , demonstrated a rapid rise in precursors of KLH-binding IgGl-secreting B cells in the spleen 5-7 d after KLH immunization. IL-4 has been suggested to play a role in B cell switching to IgG1 and in the propagation of IgG1 + AFC (16) . Consequently, the close proximity of IL-4-PC to KLH-specific B cells may stimulate the preferential development of IgG1 + B cells.
In this study we observed incidently (<1%) gp39 + cells in the corona of the follicles, but no gp39 + cells or cytokineproducing T cells were found in the GC. These observations are compatible with studies in humans (48) (49) (50) and mice (32, 51) , which demonstrated that none of the B cell differentiation factors, such as IL-2, IL-4, and IFN-% were localized in the follides of lymphoid tissue. Butch et al. (52) showed in vitro that IL-4 mRNA was the only cytokine expressed by GC T cells, whereas these T cells expressed no mRNA of the other nine tested cytokines. As this group examined cytokine mRNA expression in vitro, which is not always correlated with protein synthesis in vivo (53) , these data are not incompatible with our in vivo results.
Recently, Lederman et al. (54) demonstrated in human lymphoid tissue that the T-B cell activating molecule (T-BAM), the human equivalent of gp39, was expressed on CD4 + cells in the PALS of the spleen and in lymphoid follicles of tonsils, lymph nodes, and spleens. Essentially the human and mufine studies give identical localization patterns for gp39 expressing T cells. The observed difference in the number of positive cells in the follicles is most likely due to the fact that the murine studies are performed with a nonreplicating antigen, whereas the human material is most probably chronical inflamed (more activated T cells).
During primary immune responses, antibody production in PALS and around TA precedes the GC formation, indicating that the initial B cell activation occurs outside the follicles (55) (56) (57) . This is in agreement with the results presented in this report, showing no gp39 § cells or cytokine-PC in the follicles, but in the outer-PALS and around the TA. Only after secondary immunization, did we observe a low frequency of gp39 + cells in the corona of lymphoid follicles. The similar localization of AFC (35) , gp39 + cells, and cytokine-PC as observed in the immune response against KLH or TNP-Ficoll, suggests that T-B cell interactions during primary and secondary antibody response against TD or TI-2 antigens occur in the same splenic compartments, e.g., the outer-PALS and TA. Furthermore, it validates in vitro experiments demonstrating that the kinetics of cytokine production and CD40-1igand expression can be superimposed (7) . The observation that during the entire experimental period antigen-specific AFC and gp39 § cells were found in close proximity, in addition to in vitro experiments which showed that extended contact (more than 48 h) is required for maximal proliferative responses (58) or cytokine production (59), suggests that T-B conjugates may persist for several days in vivo. Fig. 6 shows a model for the development of TD antibody responses in the spleen based on presented data and on the localization and migration of immune cells (51) . We suggest that during the primary antibody response, TD antigens are presented by interdigitating cells in the PALS, leading to increasing numbers of antigen-specific T cells which subsequently encounter antigen-specific B cells in the PALS, forming T-B cell conjugates (60, 61) . During this cognate T-B cell interaction, CD4 + Th cells will be activated by antigenpresenting B cells and express the ligand for CD40. Gp39 will trigger B cell growth and differentiation. Part of the activated B cells migrates to the follicles to undergo follicular processes, such as B cell selection, somatic mutation, affinity maturation, and memory formation (55, 56 ). An- other part of the activated B cells migrates to the TA and differentiates into antigen-specific AFC regulated by activated cytokine-producing T cells. After secondary immunization, antigen-specific memory B cells acquire the antigen in the follicle, where it is presented by follicular dendritic cells in the form of immune complexes (55, 56) . These B cells will migrate to the PALS and meet antigen-specific T cells and will subsequently follow the pathway as described for primary immune responses. In case of secondary TD antibody responses, the follicles already contain relatively high frequencies of antigen-specific B cells, which increases the likelihood that B cells encounter antigen-specific T cells in the PALS. This may explain the relatively high frequency of activated gp39 + T cells and antigen-specific AFC found during secondary immune responses. The observation of high frequencies of antigen-specific AFC relative to gp39 § T cells (Fig.  3) , suggests that one T cell may be able to activate more than one B cell. Alternatively, the relatively low frequencies of gp39 + T ceils could be due to the shorter lasting expression of gp39 by T cells (7, 62) as compared with the expression of antigen-specific antibodies by B ceils.
In conclusion, this study demonstrates that gp39 + T cells and cytokine-PC are simultaneously upregulated in vivo after immunization. These gp39 + cells and IL-4-PC are observed in dose proximity to antigen-specific B cells. The data presented suggest that the initial cognate B ceil activation and the subsequent regulation of B cell differentiation by T cells occur in the nonfollicular areas of the spleen, namely the outer-PALS and around the TA.
